Umpqua Bank Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Umpqua Bank lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 0.6% in the 3rd quarter, Holdings Channel reports. The firm owned 6,591 shares of the company’s stock after selling 42 shares during the period. HCA Healthcare makes up 1.0% of Umpqua Bank’s investment portfolio, making the stock its 27th largest holding. Umpqua Bank’s holdings in HCA Healthcare were worth $2,679,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in HCA. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth about $28,000. Bangor Savings Bank raised its position in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. GPS Wealth Strategies Group LLC grew its stake in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare during the 2nd quarter valued at $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA stock traded down $14.68 during trading on Wednesday, hitting $351.98. The stock had a trading volume of 618,300 shares, compared to its average volume of 1,163,533. HCA Healthcare, Inc. has a twelve month low of $226.48 and a twelve month high of $417.14. The stock has a market capitalization of $89.16 billion, a P/E ratio of 16.46, a PEG ratio of 1.37 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company’s 50-day moving average price is $392.01 and its two-hundred day moving average price is $355.77.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.75%. HCA Healthcare’s payout ratio is 11.85%.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. KeyCorp reduced their price objective on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, TD Cowen cut their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $379.11.

View Our Latest Stock Report on HCA Healthcare

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.